MedPath
HSA Approval

PACLITAXEL INJECTION 6 MG/ML

SIN14476P

PACLITAXEL INJECTION 6 MG/ML

PACLITAXEL INJECTION 6 MG/ML

January 6, 2014

MYLAN PHARMACEUTICALS PTE. LTD.

MYLAN PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMYLAN PHARMACEUTICALS PTE. LTD.
Licence HolderMYLAN PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION, CONCENTRATE

INTRAVENOUS

Medical Information

L01CD01

paclitaxel

Manufacturer Information

mylan pharmaceuticals pte. ltd.

Mylan Laboratories Limited [OTL]

Active Ingredients

Paclitaxel

6mg/ml

Paclitaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.